国际医药卫生导报
國際醫藥衛生導報
국제의약위생도보
INTERNATIONAL MEDICINE & HEALTH GUIDANCE NEWS
2013年
23期
3550-3553
,共4页
冼翠华%罗明乾%石晓峰%钟业娟%轩慧杰%胡国强%苏明
冼翠華%囉明乾%石曉峰%鐘業娟%軒慧傑%鬍國彊%囌明
승취화%라명건%석효봉%종업연%헌혜걸%호국강%소명
甲状旁腺切除术%移植%自体%尿毒症%甲状旁腺功能亢进症%继发性
甲狀徬腺切除術%移植%自體%尿毒癥%甲狀徬腺功能亢進癥%繼髮性
갑상방선절제술%이식%자체%뇨독증%갑상방선공능항진증%계발성
Parathroidectomy%Transplantation%Autologous%Uremia%Hyperparathyroidism%Secondary
目的 研究尿毒症患者因继发性甲状旁腺功能亢进(SHPT)行甲状旁腺全切除加自体上臂移植术(TPTX+AT)的临床疗效.方法 回顾分析我院30例因慢性肾脏病长期接受规律性透析的患者发生难治性SPTH,予行甲状旁腺全切除加自体上臂移植术,比较患者术前、术后全段甲状旁腺激素(iPTH)、血清钙、磷及碱性磷酸酶(ALP)、血红蛋白(Hb)的变化情况、临床症状改善情况,从而判断疗效.结果 30例患者中,无一例死亡;2例患者发生喉返神经损伤,发生率为6.67%.术后低钙发生率高(79.5%,25/30),均经积极静脉补钙后有效控制.患者术后各时间点(1天、1周、1、3、6个月)血iPTH、血清磷、血清钙均较术前显著下降(P<0.01).术后3、6个月血清ALP较术前显著下降(P<0.01),而Hb较术前明显升高(P<0.05).术后患者骨痛、皮肤瘙痒、肌无力、失眠、不宁腿、贫血等得到明显改善,全身营养状态好转.结论 甲状旁腺全切除加自体上臂移植术能安全、有效治疗尿毒症难治性SHPT.
目的 研究尿毒癥患者因繼髮性甲狀徬腺功能亢進(SHPT)行甲狀徬腺全切除加自體上臂移植術(TPTX+AT)的臨床療效.方法 迴顧分析我院30例因慢性腎髒病長期接受規律性透析的患者髮生難治性SPTH,予行甲狀徬腺全切除加自體上臂移植術,比較患者術前、術後全段甲狀徬腺激素(iPTH)、血清鈣、燐及堿性燐痠酶(ALP)、血紅蛋白(Hb)的變化情況、臨床癥狀改善情況,從而判斷療效.結果 30例患者中,無一例死亡;2例患者髮生喉返神經損傷,髮生率為6.67%.術後低鈣髮生率高(79.5%,25/30),均經積極靜脈補鈣後有效控製.患者術後各時間點(1天、1週、1、3、6箇月)血iPTH、血清燐、血清鈣均較術前顯著下降(P<0.01).術後3、6箇月血清ALP較術前顯著下降(P<0.01),而Hb較術前明顯升高(P<0.05).術後患者骨痛、皮膚瘙癢、肌無力、失眠、不寧腿、貧血等得到明顯改善,全身營養狀態好轉.結論 甲狀徬腺全切除加自體上臂移植術能安全、有效治療尿毒癥難治性SHPT.
목적 연구뇨독증환자인계발성갑상방선공능항진(SHPT)행갑상방선전절제가자체상비이식술(TPTX+AT)적림상료효.방법 회고분석아원30례인만성신장병장기접수규률성투석적환자발생난치성SPTH,여행갑상방선전절제가자체상비이식술,비교환자술전、술후전단갑상방선격소(iPTH)、혈청개、린급감성린산매(ALP)、혈홍단백(Hb)적변화정황、림상증상개선정황,종이판단료효.결과 30례환자중,무일례사망;2례환자발생후반신경손상,발생솔위6.67%.술후저개발생솔고(79.5%,25/30),균경적겁정맥보개후유효공제.환자술후각시간점(1천、1주、1、3、6개월)혈iPTH、혈청린、혈청개균교술전현저하강(P<0.01).술후3、6개월혈청ALP교술전현저하강(P<0.01),이Hb교술전명현승고(P<0.05).술후환자골통、피부소양、기무력、실면、불저퇴、빈혈등득도명현개선,전신영양상태호전.결론 갑상방선전절제가자체상비이식술능안전、유효치료뇨독증난치성SHPT.
Objective To study the clinical effect of total parathroidectomy combined with upper arm autograft (TPTX + AT) in the treatment of uremic patients with secondary hyperparathyroidism (SHPT).Methods 30 refractory SHPT patients caused by long-term regular dialysis because of chronic renal disease underwent TPTX + AT.Determined the clinical efficacy by comparing the levels of intact parathyroid hormone (iPTH),serum calcium,serum phosphate,alkaline phosphatase (ALP),hemoglobin (Hb) and clinical symptoms before and after operation.Results No one in 30 cases died after operation.Recurrent laryngeal nerve injury was found in 2 cases (6.6%),postoperative hypocalcemia in 25 cases (79.5%),effectively controlled by intravenous calcium.The levels of iPTH,serum phosphorus,serum calcium 1 day,1 week,1 month,3 months and 6 months after operation significantly lowered than those before operation(P < 0.01).The level of ALP 3,6 months after operation significantly lowered than those before operation (P < 0.01),the level of Hb rose(P < 0.05).Bone pain,itching,myasthenia,insomnia,restless legs syndrome,anemia and nutritional status significantly improved.Conclusion TPTX + AT is a safe and effective treatment method for uremic patients with refractory SHPT.